Organization
Roche Products, Pty. Ltd, Dee Why, Australia
1 abstract
Abstract
AC-CUTE: AN OPEN-LABEL STUDY TO EVALUATE NON-PROGRESSION OF STRUCTURAL JOINT DAMAGE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB Org: Spire Sciences, Inc., Boca Raton, United States, Combined Rheumatology Practice, Kogarah, Cabrini Medical Centre, Malvern, Barwon Rheumatology Service, Geelong, Roche Products, Pty. Ltd, Dee Why, Australia,